Literature DB >> 24948331

Functional mapping of community-acquired respiratory distress syndrome (CARDS) toxin of Mycoplasma pneumoniae defines regions with ADP-ribosyltransferase, vacuolating and receptor-binding activities.

Thirumalai R Kannan1, Manickam Krishnan, Kumaraguruparan Ramasamy, Argentina Becker, Olga N Pakhomova, P John Hart, Joel B Baseman.   

Abstract

Community-acquired respiratory distress syndrome (CARDS) toxin from Mycoplasma pneumoniae is a 591-amino-acid virulence factor with ADP-ribosyltransferase (ADPRT) and vacuolating activities. It is expressed at low levels during in vitro growth and at high levels during colonization of the lung. Exposure of experimental animals to purified recombinant CARDS toxin alone is sufficient to recapitulate the cytopathology and inflammatory responses associated with M. pneumoniae infection in humans and animals. Here, by molecular modelling, serial truncations and site-directed mutagenesis, we show that the N-terminal region is essential for ADP-ribosylating activity. Also, by systematic truncation and limited proteolysis experiments we identified a portion of the C-terminal region that mediates toxin binding to mammalian cell surfaces and subsequent internalization. In addition, the C-terminal region alone induces vacuolization in a manner similar to full-length toxin. Together, these data suggest that CARDS toxin has a unique architecture with functionally separable N-terminal and C-terminal domains.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24948331      PMCID: PMC4116743          DOI: 10.1111/mmi.12680

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  51 in total

Review 1.  A family of killer toxins. Exploring the mechanism of ADP-ribosylating toxins.

Authors:  Kenneth P Holbourn; Clifford C Shone; K R Acharya
Journal:  FEBS J       Date:  2006-09-05       Impact factor: 5.542

2.  Two distinct cytotoxic activities of subtilase cytotoxin produced by shiga-toxigenic Escherichia coli.

Authors:  Naoko Morinaga; Kinnosuke Yahiro; Gen Matsuura; Masaharu Watanabe; Fumio Nomura; Joel Moss; Masatoshi Noda
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

3.  Structure of the mosquitocidal toxin from Bacillus sphaericus.

Authors:  Dirk J Reinert; Irina Carpusca; Klaus Aktories; Georg E Schulz
Journal:  J Mol Biol       Date:  2006-01-27       Impact factor: 5.469

4.  Structural basis for the activation of cholera toxin by human ARF6-GTP.

Authors:  Claire J O'Neal; Michael G Jobling; Randall K Holmes; Wim G J Hol
Journal:  Science       Date:  2005-08-12       Impact factor: 47.728

5.  Identification and characterization of human surfactant protein A binding protein of Mycoplasma pneumoniae.

Authors:  T R Kannan; D Provenzano; J R Wright; J B Baseman
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

Review 6.  Mycoplasma pneumoniae and its role in asthma.

Authors:  Nazima Nisar; Randeep Guleria; Sanjay Kumar; Tirlok Chand Chawla; Nihar Ranjan Biswas
Journal:  Postgrad Med J       Date:  2007-02       Impact factor: 2.401

7.  ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens.

Authors:  T R Kannan; Joel B Baseman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-14       Impact factor: 11.205

Review 8.  Asthma and atypical bacterial infection.

Authors:  E Rand Sutherland; Richard J Martin
Journal:  Chest       Date:  2007-12       Impact factor: 9.410

9.  The HHpred interactive server for protein homology detection and structure prediction.

Authors:  Johannes Söding; Andreas Biegert; Andrei N Lupas
Journal:  Nucleic Acids Res       Date:  2005-07-01       Impact factor: 16.971

Review 10.  Molecular mechanisms of the cytotoxicity of ADP-ribosylating toxins.

Authors:  Qing Deng; Joseph T Barbieri
Journal:  Annu Rev Microbiol       Date:  2008       Impact factor: 16.232

View more
  18 in total

1.  Structure of CARDS toxin, a unique ADP-ribosylating and vacuolating cytotoxin from Mycoplasma pneumoniae.

Authors:  Argentina Becker; T R Kannan; Alexander B Taylor; Olga N Pakhomova; Yanfeng Zhang; Sudha R Somarajan; Ahmad Galaleldeen; Stephen P Holloway; Joel B Baseman; P John Hart
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-06       Impact factor: 11.205

2.  Disulfide bond of Mycoplasma pneumoniae community-acquired respiratory distress syndrome toxin is essential to maintain the ADP-ribosylating and vacuolating activities.

Authors:  Sowmya Balasubramanian; Lavanya Pandranki; Suzanna Maupin; Kumaraguruparan Ramasamy; Alexander B Taylor; Peter John Hart; Joel B Baseman; Thirumalai R Kannan
Journal:  Cell Microbiol       Date:  2019-05-09       Impact factor: 3.715

3.  NLRP3 Is a Critical Regulator of Inflammation and Innate Immune Cell Response during Mycoplasma pneumoniae Infection.

Authors:  Jesus A Segovia; Te-Hung Chang; Vicki T Winter; Jacqueline J Coalson; Marianna P Cagle; Lavanya Pandranki; Santanu Bose; Joel B Baseman; Thirumalai R Kannan
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

4.  Comparative genome analysis of Mycoplasma pneumoniae.

Authors:  Li Xiao; Travis Ptacek; John D Osborne; Donna M Crabb; Warren L Simmons; Elliot J Lefkowitz; Ken B Waites; T Prescott Atkinson; Kevin Dybvig
Journal:  BMC Genomics       Date:  2015-08-16       Impact factor: 3.969

5.  ADP-ribosylation of NLRP3 by Mycoplasma pneumoniae CARDS toxin regulates inflammasome activity.

Authors:  Santanu Bose; Jesus A Segovia; Sudha R Somarajan; Te-Hung Chang; T R Kannan; Joel B Baseman
Journal:  MBio       Date:  2014-12-23       Impact factor: 7.867

6.  Annexin A2 mediates Mycoplasma pneumoniae community-acquired respiratory distress syndrome toxin binding to eukaryotic cells.

Authors:  Sudha R Somarajan; Fadi Al-Asadi; Kumaraguruparan Ramasamy; Lavanya Pandranki; Joel B Baseman; T R Kannan
Journal:  mBio       Date:  2014-08-19       Impact factor: 7.867

7.  Mycoplasma pneumoniae CARDS toxin exploits host cell endosomal acidic pH and vacuolar ATPase proton pump to execute its biological activities.

Authors:  Kumaraguruparan Ramasamy; Sowmya Balasubramanian; Alejandra Kirkpatrick; Daniel Szabo; Lavanya Pandranki; Joel B Baseman; T R Kannan
Journal:  Sci Rep       Date:  2021-06-02       Impact factor: 4.379

Review 8.  Potential Molecular Targets for Narrow-Spectrum Agents to Combat Mycoplasma pneumoniae Infection and Disease.

Authors:  Mitchell F Balish; Steven L Distelhorst
Journal:  Front Microbiol       Date:  2016-02-25       Impact factor: 5.640

9.  Immunoproteomic identification of MbovP579, a promising diagnostic biomarker for serological detection of Mycoplasma bovis infection.

Authors:  Farhan Anwar Khan; Muhammad Faisal; Jin Chao; Kai Liu; Xi Chen; Gang Zhao; Harish Menghwar; Hui Zhang; Xifang Zhu; Muhammad Asif Rasheed; Chenfei He; Changmin Hu; Yingyu Chen; Eric Baranowski; Huanchun Chen; Aizhen Guo
Journal:  Oncotarget       Date:  2016-06-28

Review 10.  Inflammation-inducing Factors of Mycoplasma pneumoniae.

Authors:  Takashi Shimizu
Journal:  Front Microbiol       Date:  2016-03-31       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.